Is INMD stock a good Buy?
Is INMODE Stock a good buy in 2022, according to Wall Street analysts? The consensus among 3 Wall Street analysts covering (NASDAQ: INMD) stock is to Strong Buy INMD stock.
What is happening with InMode?
Shares of medical device company InMode (NASDAQ: INMD) fell 32% in April, according to data provided by S&P Global Market Intelligence. On April 11, the company gave encouraging preliminary financial results for the first quarter of 2022.
Should I buy InMode stock?
What is InMode worth? Good news, investors! InMode is still a bargain right now according to my price multiple model, which compares the company's price-to-earnings ratio to the industry average. I've used the price-to-earnings ratio in this instance because there's not enough visibility to forecast its cash flows.
What does INMD make?
designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally.
What is InMode aesthetic solutions?
InMode connects physicians to the latest technologies that can optimize results for your patients and your business. Our non-invasive and minimally invasive technologies provide solutions for contouring, skin treatment, acne, hair removal, anti-aging, wellness, pigment and vascular issues.
Is InMode a buy Zacks?
See rankings and related performance below. The VGM Score are a complementary set of indicators to use alongside the Zacks Rank....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy25.08%2Buy18.56%3Hold10.15%4Sell5.79%2 more rows